JointAlive®: Successful NDI Notification for Innovative Botanical Formulation NDIN 1172

After more than 2-months of review by the FDA committee, we are pleased to announce that Chenland’s Patented Brand Ingredient JointAlive® has officially received NDI approval from #FDA (NDIN 1172).

By obtaining the FDA-NDI approval, JointAlive® now can be safely used in dietary supplements under the conditions of use recommended. The FDA-NDI certification also proves the strong R&D strength and production potential of Chenland Nutritionals.

, Jointalive NDI, chenland, chenland

NDI is the abbreviation of New Dietary Ingredients. The term “new dietary ingredient” means a dietary ingredient that was not marketed in the United States in a dietary supplement before October 15, 1994. The Federal Food, Drug, and Cosmetic Act (the FD&C Act) requires that manufacturers and distributors who wish to market dietary supplements that contain “new dietary ingredients” notify the Food and Drug Administration about these ingredients. (See Section 413(d) of the FD&C Act, 21 U.S.C. 350b(d).) Generally, the notification must include information that is the basis on which the manufacturer or distributor has concluded that a dietary supplement containing a new dietary ingredient will reasonably be expected to be safe under the conditions of use recommended or suggested in the labeling.[1] The dietary supplements containing new dietary ingredients can only be marketed in the United States after specifically approved by the FDA.

JointAlive® is Chenland’s premier joint support solution with clinically proven formula. It is a specially formulated botanical blend with three traditional Asian herbs: Epimedium brevicornum Maxim, Discorea nipponica Makino and Salvia miltiorrhiza Bunge. The development of JointAlive® is based on 2,000 years Traditional Chinese Medicine history and the traceability is guaranteed through strict quality control throughout the production process. JointAlive® has various health benefits, including maintaining healthy joint functions, relieving joint pain, supporting joint flexibility and mobility, as well as reducing joint inflammation and swelling.

With Chenland’s strong scientific research strength and product safety assurance, the future is ours to win.

, Jointalive NDI, chenland, chenland

[1] U.S. Food & Drug Administration. (2020.10.26). New Dietary Ingredients in Dietary Supplements Background for Industry. Retrieved from https://www.fda.gov/food/new-dietary-ingredients-ndi-notification-process/new-dietary-ingredients-dietary-supplements-background-industry